You are viewing an incomplete version of our website. Please click to reload the website as full version.

CASP2 and RIPK1 Domain Containing Adaptor with Death Domain (CRADD) (Internal Region) Peptide

Details for Product No. ABIN1381971, Supplier: Log in to see
Protein Name
  • cradd
  • MGC89035
  • zgc:101717
  • CRADD
  • DKFZp468A2219
  • LOC100226369
  • raidd
  • MGC78788
  • MRT34
  • RAIDD
Protein Region
Internal Region
Origin
Human
3
2
2
Application
Blocking Peptide (BP)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Blocked Antibody anti-CRADD antibody (CASP2 and RIPK1 Domain Containing Adaptor with Death Domain) (Middle Region) (ABIN1031051)
Characteristics 19 amino acids near the center of human RAIDD.
Human
Research Area Cancer, Apoptosis/Necrosis
Application Notes RAIDD peptide is used for blocking the activity of RAIDD.
Restrictions For Research Use only
Format Liquid
Concentration 200 μg/mL
Buffer PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Expiry Date 12 months
Background publications He, Chen, Farzan et al.: "CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia." in: Nature, Vol. 385, Issue 6617, pp. 645-9, 1997 (PubMed).

Duan, Dixit: "RAIDD is a new 'death' adaptor molecule." in: Nature, Vol. 385, Issue 6611, pp. 86-9, 1997 (PubMed).

Choe, Farzan, Sun et al.: "The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates." in: Cell, Vol. 85, Issue 7, pp. 1135-48, 1996 (PubMed).